This article was written by

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The article is for informational purposes only (not a solicitation or recommendation to buy or sell stocks). David is not a registered investment adviser. Investors should do their own research or consult a financial adviser to determine what investments are appropriate for their individual situation. This article expresses my opinions, and I cannot guarantee that the information/results will be accurate. Investing in stocks involves risk and could result in losses.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

This article was written by

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Shares of IDFC First Bank rallied as much as 9% to Rs 88 on the BSE on Monday after the lender reported its highest-ever quarterly profit after tax (PAT) of Rs 1,075 crore for the quarter ended June 30, 2026. The profit jumped 132.4% year-on-year (YoY) from Rs 463 crore in the corresponding quarter last year.

The bank, however, disclosed that it received claims worth Rs 514.8 crore under the CGFMU scheme against its MFI portfolio during the quarter.

Net interest income (NII) rose 21.1% YoY to Rs 5,972.3 crore from Rs 4,933 crore a year earlier. The bank’s net interest margin (NIM) also improved to 5.96% in Q1 FY27 from 5.71% in Q1 FY26, marking an expansion of 25 basis points. On a sequential basis, NIM increased by 3 basis points.

Also Read | Costs and provisions down, IDFC Bank will continue to bolster earnings: V Vaidyanathan, MD & CEO

Asset quality showed further improvement. Gross non-performing assets (NPA) fell to 1.51% as of June 30, 2026, from 1.97% a year earlier, an improvement of 45 basis points. Gross NPA also declined by 10 basis points on a quarter-on-quarter basis.

IDFC Bank share price target

Emkay maintained its ADD rating with a target price of Rs 85 (5% upside) per share. It said PAT surged 132% YoY to Rs 1,080 crore, crossing the Rs 21,000 crore mark for the first time, driven by higher NII, strong fee income and lower provisions. Emkay expects positive operating jaws and lower provisioning to support an improvement in ROA over the next few years.
Motilal Oswal maintained its Neutral rating with a target price of Rs 90 per share, implying an 11% upside. The brokerage said IDFC First Bank delivered a strong quarter, supported by healthy operating performance and improved asset quality, aided by one-off interest on an IT refund and strong treasury gains.
Adjusted NIM declined 3 bps QoQ to 5.9%, with management expecting further contraction during the year and guiding for an NIM of 5.8%. Deposit growth remained healthy, driven by strong traction in CASA deposits and higher certificates of deposits, while loan growth was strong, supported by steady momentum in retail and a pick-up in wholesale segments.

Also Read | Nifty’s 5-day fall may be nearing a reversal; Anand James maps key levels for this week

Management commentary

The lender said it remains focused on building a high-quality banking institution with strong governance standards and is seeing healthy business momentum.

Management said asset quality continued to strengthen, with gross NPA at 1.51% and net NPA at 0.44%. Provisions as a percentage of loans also continued to decline. During the quarter, the bank received a CGFMU claim of Rs 515 crore and, as a prudent measure, created a provision of Rs 515 crore to account for any potential impact from monsoon conditions or fuel price volatility during the rest of the year.

Managing Director and CEO V Vaidyanathan said that investments made in building the bank are now beginning to translate into operating leverage, supporting the rise in PAT to Rs 1,075 crore in Q1 FY27. Return on assets (ROA) also crossed 1%.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Shares of Hindustan Zinc rose 2% to their day’s high of Rs 541 on the BSE on Monday as multiple brokerages reiterated their ‘Buy’ calls for the Vedanta Group company after it reported a whopping 145% year-on-year (YoY) surge in net profit to Rs 5,469 crore for the first quarter of FY27.

Hindustan Zinc, India’s largest producer of silver, on Friday released its results for the April-June quarter of the ongoing financial year 2027. Its revenue from operations rose around 77% YoY to Rs 13,747 crore during the quarter under review, from Rs 7,771 crore reported in the same period last year. Total expenses increased over 33% YoY to Rs 6,749 crore during the quarter, which ended on June 30, 2026.

The Vedanta Group company’s net profit margin improved to 40% in the April-June quarter of FY27, from 37% in the previous quarter (Q4 FY26) and 29% in the year-ago period (Q1 FY26). Operating margin, meanwhile, increased to 52% during the quarter under review.

The metal major’s net worth also more than doubled on a YoY basis, rising around 108% to Rs 23,587 crore at the end of the June quarter of the ongoing financial year 2027. Its debt-to-equity ratio stood at 0.32 times, as against 1.19 times in Q1 FY26.

Nuvama on Hindustan Zinc share price

Nuvama Institutional Equities noted that Hindustan Zinc’s Q1 EBITDA of Rs 7,990 crore was nearly in line with estimates amid higher prices, partly offset by seasonally lower volume. . Refined Zinc cost of production (ex-royalty) stood lower at $851/ton (down $52/ton QoQ) amid benefits of higher sulphuric acid prices and rupee depreciation, it said.

Silver EBIT was down 2% sequentially due to lower volume and comprised 46% of EBIT in Q1, the brokerage added. “The tight supply market is likely to keep zinc prices relatively high while silver prices are likely to remain firm. We forecast a 3% volume CAGR for refined metal and a 4% volume CAGR for silver over FY26–28E. Higher prices and cost control shall drive EBITDA at 20% CAGR over FY26–28. The 250ktpa zinc smelter expansion shall be commissioned by Q2 FY29,” it added.

Nuvama has a ‘Buy’ call on the shares of Hindustan Zinc with a target price of Rs 700 per share, implying around 32% upside potential from the stock’s previous closing price of Rs 531.95 apiece.

Also read | Hindustan Zinc names Amarendu Prakash as new CEO; quarterly profit more than doubles on strong metal prices

JM Financial on Hindustan Zinc share price

JM Financial said Hindustan Zinc’s Q1 EBITDA beat its estimate, driven by lower cost of production. “We remain positive on HZL given its industry-leading cost position, strong balance sheet and long-term growth pipeline,” it said.
The domestic brokerage maintained its ‘Buy’ call on the stock with a target price of Rs 660 apiece, implying 24% upside potential.

Motilal Oswal on Hindustan Zinc share price

Motilal Oswal Financial Services said Hindustan Zinc delivered a slight beat on estimates, with revenue growth being driven by favorable commodity prices, higher by-product realization, and a stronger dollar.
EBITDA’s beat on forecast was primarily driven by favorable metal prices and lower cost of production. “Hindustan Zinc continues to report strong earnings, primarily driven by favorable metal pricing and better grades. The company continues to focus on increasing production output with tighter cost-control measures, which could lead to margin sustenance. The recently announced expansion plans are aligned with its long-term objective of doubling existing capacity and enhancing long-term earnings visibility. Although near-term earnings growth is capped due to limited capacity headroom, the LME/silver price inflation emerges as the key catalyst for incremental upside in the near term. We maintain our FY27/28 estimates and believe further price volatility could remain a potential risk or reward for earnings visibility,” it added.

Motilal Oswal however noted that the current valuation has priced in all the positive factors. It reiterated its ‘Neutral’ call on the stock with a target price of Rs 570 apiece.

Also read | Hindustan Zinc Q1 Results: Net profit spikes 145% YoY to Rs 5,469 crore, revenue jumps 77%

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

FMCG major Tata Consumer Products gained 3% to Rs 1,123 on the BSE on Monday after reporting a 27.8% year-on-year (YoY) rise in consolidated net profit to Rs 427 crore for the April-June quarter of FY27, compared with Rs 334 crore in the year-ago period.

Revenue from operations rose 11.9% YoY to Rs 5,349 crore in Q1 FY27 from Rs 4,779 crore in the corresponding quarter of the previous financial year. Total expenses also increased 11% YoY to Rs 4,829 crore during the quarter.

Should you buy, sell or hold Tata Consumer shares?

Nomura, with a Buy rating and a target price of Rs 1,475 (36% upside), said Tata Consumer introduced calibrated price hikes of 1-2% in tea and 6% in salt in June, which should support both sales growth and margins. With tea inflation currently at around 7-10% and new crop procurement still in the early stages, management has indicated that further price hikes, likely towards the end of Q2, will be implemented to protect margins. Nomura expects early double-digit sales growth to continue in FY27F.

The brokerage marginally revised its FY27F-FY29F EPS estimates to factor in lower tea growth due to price cuts and forecasts a 16.5% EPS CAGR over FY26-FY29F. It values Tata Consumer using a DCF model and has raised its target price to Rs 1,475 from Rs 1,450, implying a target P/E multiple of 60x. Key risks include weaker growth in the company’s growth businesses and margin pressure.

Motilal Oswal, with a Buy call and a target price of Rs 1,500 (38% upside), expects Tata Consumer’s growth momentum to strengthen further, supported by improving go-to-market (GTM) execution, rising e-commerce penetration, premium product launches, and continued expansion of high-growth businesses such as Tata Sampann, RTD Beverages, Capital Foods, and Organic India. The brokerage expects operating margins to improve over the coming years, driven by portfolio premiumisation, innovation-led product expansion, and a rising contribution from higher-margin growth businesses and health and wellness categories.

JM Financial also assigned a Buy rating with a target price of Rs 1,225 (13% upside). It said Tata Consumer’s Q1 FY27 sales and EBITDA performance were in line with its expectations. Key positives included healthy acceleration in growth businesses, led by Tata Sampann, which grew 58%, NourishCo, and a strong 40% recovery in Capital Foods, along with better-than-expected gross margins supported by benign tea prices and improved international margins.
The brokerage expects sustained momentum in growth businesses, stable international operations, and a recovery in domestic volumes to support double-digit revenue growth. It expects price hikes, year-on-year moderation in coffee prices—which should benefit international margins—operating leverage, and cost-saving initiatives to drive EBITDA margin expansion, with the company reiterating its guidance for a 50-70 bps expansion in FY27.
Nuvama retained its Buy rating and target price of Rs 1,435 per share, saying the company’s Q1 results were broadly in line with expectations. The brokerage highlighted 14 new product launches during the quarter, which it said strengthened Tata Consumer’s innovation pipeline. However, revenue from the non-branded business declined 10% YoY in constant currency terms.
Read more: ITC, HUL among 10 FMCG stocks that have tumbled up to 31% in 2026. How many do you have?

Management commentary

“We delivered yet another quarter of double-digit topline growth, backed by volume growth,” Tata Consumer Products Managing Director and CEO Sunil D’Souza said. He said the India business recorded robust underlying volume growth, reflecting the company’s continued focus on execution, category expansion and innovation.

Also read: Tata Consumer Products to pass higher input costs to buyers

D’Souza added that the company’s “Growth” businesses performed strongly and increased their overall contribution to the India business. Tata Sampann continued to deliver exceptional growth, supported by strong performance across dry fruits, cold-pressed oils, core pulses and spices. The Ready-To-Drink business also had a strong quarter, with growth across its core brands as well as new launches, he said.

Tata Consumer share price

Over a longer period, however, Tata Consumer shares have gained 2% in a year, 28% in three years and more than 42% in five years. The company has a market capitalisation of over Rs 1.08 lakh crore.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Shares of Bank of Baroda dipped 2% to Rs 242 on the BSE on Monday after the lender reported a 72% year-on-year (YoY) drop in net profit to Rs 1,278 crore for the first quarter of FY27, absorbing a one-off exceptional item of $600 million. Multiple brokerages downgraded their ratings and slashed target prices for the stock after the earnings print.

Bank of Baroda on Friday reported that its net interest income (NII) rose 9% YoY to Rs 12,524 crore during the April-June quarter of FY27, as against Rs 11,435 crore in the year-ago period. Operating income fell slightly to Rs 15,995 crore, while operating profit dropped 1% YoY to Rs 8,127 crore.

Total provisions and contingencies rose to Rs 6,323 crore, mainly due to the exceptional item. The bank’s global advances grew 17% YoY to Rs 14.16 lakh crore, while global deposits rose 14% YoY to Rs 16.33 lakh crore. Global net interest margin stood at 2.77% for Q1 FY27, compared with 2.91% a year earlier and 2.89% in Q4 FY26. Domestic NIM stood at 2.93%. Cost of deposits declined to 4.66%, down 12 basis points sequentially and 39 basis points year-on-year.

Bank of Baroda’s asset quality improved from a year earlier, though bad loan ratios rose sequentially. Gross NPA ratio stood at 1.99% in Q1 FY27, compared with 2.28% in Q1 FY26 and 1.89% in Q4 FY26. Net NPA ratio declined to 0.50% from 0.60% a year earlier, but was higher than 0.45% in the March quarter.

JM Financial on Bank of Baroda share price

JM Financial said Bank of Baroda reported a mixed Q1 earnings print, with a 72% plunge in profit due to an exceptional charge pertaining to the NMC Health litigation settlement. Excluding this, PAT would have grown 22% YoY, translating to an RoA of 1.1%, it noted.

Operating performance was further weighed down by weak core fee income, declining 22% YoY and missing the brokerage’s estimate by 36%, although sharply lower provisions, aided by release of standard asset provisions, supported profitability, JM Financial said. It added that advances growth came as the bank consciously ran down corporate exposures.
Sustaining RoA above 1% remains a key variable to monitor amid potential NIM pressure, continued reliance on recoveries and potentially higher credit costs following the upcoming ECL transition, the brokerage said. It cut its EPS estimates for FY27 by 5% and FY28 by 1% to factor in the NMC litigation charge, higher credit costs and moderation in fee income.
JM Financial maintained its ‘Add’ rating on the shares of Bank of Baroda, but reduced its target price to Rs 270 apiece from Rs 290. The latest target implies a 10% upside from the previous closing price of Rs 246.45 on NSE.
Also read | Bank of Baroda Q1 Results: Profit falls 72% to Rs 1,278 crore on one-off settlement hit

Motilal Oswal on Bank of Baroda share price

Motilal Oswal Financial Services said Bank of Baroda reported a muted quarter, with the one-off provision weighing on earnings. It noted that the bank expects NIMs to remain broadly in the 2.75% to 2.95% range, while cost of funds appears to have largely bottomed out, with incremental support expected from improving yields.

Business momentum was soft this quarter, with management maintaining credit growth guidance of 12% to 14% going ahead.

While there are no inherent concerns on asset quality, the brokerage expects credit costs to stay high at around 60 basis points in FY28, factoring in the ECL-related transition. It reduced earnings estimates by 18.9% for FY27 and 5.2% for FY28 due to the one-time settlement impact.

Motilal Oswal maintained its ‘Neutral’ rating but cut its target price to Rs 275, implying nearly 12% upside.

Other brokerages

Systematix Institutional Equities said that excluding the one-off item, core performance remained healthy. However, it reduced earnings estimates to factor in margin pressure and other financial factors. It cut the target price to Rs 290 from Rs 300, while maintaining a ‘Buy’ call.

Dolat Capital maintained its ‘Reduce’ rating and lowered the target price to Rs 250, implying just over 1% upside. It expects RoA to decline to 0.9% in FY28 due to lower margins and upcoming ECL provisions. Its loan growth estimate of 12% over FY27 and FY28 is also below overall banking system expectations.

Also read | NMC health settlement drags Bank of Baroda Q1 net profit down 72%

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)